Skip to product information

2021 Pathology Review: Gynecologic, Breast and Soft Tissue for the General Pathologist

2021 Pathology Review: Gynecologic, Breast and Soft Tissue for the General Pathologist

Regular price $50.00 USD
Regular price $50.00 USD Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
2021 Pathology Review: Gynecologic, Breast and Soft Tissue for the General Pathologist

2021 Pathology Review: Gynecologic, Breast and Soft Tissue for the General Pathologist

Regular price $50.00
Regular price $50.00 Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    [

    2021 Pathology Review: Gynecologic, Breast and Soft Tissue for the General Pathologist

    Educational Objectives :

    At the completion of this CME teaching activity, you should be able to:

    •  Discuss the challenges radiologists face when caring for a pediatric patient.
    • Differentiate serous, endometrial and sex cord tumors of the gynecologic track.
    •  Discuss the challenges associated with cervical lesions of the uterus.
    •  Achieve a better understanding of practical placental pathology.
    •  Identify inflammatory and reactive lesions of the breast.
    •  Achieve a greater understanding of problematic issues in breast core needle biopsies.
    •  Analyze post-neoadjuvant breast specimens.
    •  Identify spindle cell and vascular tumors of the breast.
    •  Discuss the recent updates to the ER/PR and HER2 testing guidelines.
    •  Apply molecular testing in the management of breast cancer.
    •  Achieve a better understanding of mesenchymal tumors of the uterus.
    •  Review problematic in situ lesions of the breast.
    • Achieve a better understanding of the challenges associated with melanocytic lesions in the pediatric population.
    •  Discuss the continuing dilemma of ductal carcinoma in situ.
    •  Review pseudolymphomas.

    Program :

    Serous Neoplasia of the Ovary
    Mara H. Rendi, M.D., Ph.D.

    Endometrial Neoplasia, Subtypes, Mimics and Molecular Testing
    Mara H. Rendi, M.D., Ph.D.

    Sex Cord Stromal Tumors of the Gynecologic Track
    Mara H. Rendi, M.D., Ph.D.

    Problematic Issues in Breast Core Needle Biopsies
    Stuart J. Schnitt, M.D.

    Inflammatory and Reactive Lesions of the Breast
    Stuart J. Schnitt, M.D.

    Evaluation of the Post-Neoadjuvant Chemotherapy Breast Specimen
    Stuart J. Schnitt, M.D.

    The Spectrum of Triple Negative Breast Cancer
    Stuart J. Schnitt, M.D.

    Pseudolymphomas
    Alejandro Ariel Gru, M.D.

    Update in Cutaneous Lymphomas in the WHO Classification
    Alejandro Ariel Gru, M.D.

    Superficial Mesenchymal Tumors in the Pediatric Setting
    Alejandro Ariel Gru, M.D.

    Cutaneous Histiocytic Neoplasms
    Alejandro Ariel Gru, M.D.

    The Challenging Melanocytic Lesions in the Pediatric Population
    Alejandro Ariel Gru, M.D.

    Challenging Cervical Lesions of the Uterus
    Mara H. Rendi, M.D., Ph.D.

    Mesenchymal Tumors of the Uterus
    Mara H. Rendi, M.D., Ph.D.

    Practical Placental Pathology
    Mara H. Rendi, M.D., Ph.D.

    Problematic In Situ Lesions of the Breast
    Stuart J. Schnitt, M.D.

    Spindle Cell and Vascular Lesions of the Breast
    Stuart J. Schnitt, M.D.

    The Continuing Dilemma of Ductal Carcinoma in Situ
    Stuart J. Schnitt, M.D.

    Molecular Testing & ER/PR, HER2 Guidelines in the Management of Patients with Breast Cancer
    Stuart J. Schnitt, M.D.

    ]